30 November 2002
Predicting the Grade of Banff 97 Classification of Chronic Allograft Nephropathy Based on Examination of Graft Dysfunction (a Preliminary Report)
O Schück, O Viklický, L Voska, S Vítko, V Teplan, J Lácha, A Jabor, J Skibová, M ŠtollováAnn Transplant 2003; 8(3): 5-7 :: ID: 7519
Abstract
Objectives: Progression of chronic allograft nephropathy (CAN) is associated with a progressive decrease in graft function. Prediction of the Banff CAN grade on the basis of correlation between the grade of histological changes and Scr is difficult because of the big spread of individual values. This study sought to predict the Banff CAN grade based on Scr, Ccr and proteinuria using ROC analysis. Methods: Graft protocol biopsy and functional testing (Scr, Ccr and proteinuria) were performed in 77 subjects (43 men, 34 women, mean age 48.4±12.8 years) at 33.8±1.0 months after their first renal transplantation. Immunosuppression was provided with the triple combination of cyclosporin A, prednisone and azathioprine (or mycophenolate mofetil). Statistical evaluation was performed using receiver-operating curve (ROC) analysis. The cut-off value of the Banff CAN score was set at 1. Results: The mean values and SD of the investigated functional parameters in study subjects were as follows: Scr = 201.5 (±100.0) µmol/l Ccr = 48.1 (±21.2) ml/min/1.73 m2, proteinuria = 0.89 (±1.96) g/24 h. ROC analysis showed the highest AUC (±SEM) for Scr 0.806 (±0.063). The respective values were 0.790 (±0.053) for Ccr and 0.643 (±0.075) for proteinuria. The AUC (area under the ROC curve) for Scr was significantly higher (P275 µmol/l and Ccr
In Press
07 Mar 2024 : Original article
Outcomes of Renal Transplantation in ANCA-Associated VasculitisAnn Transplant In Press; DOI: 10.12659/AOT.943433
08 Mar 2024 : Original article
Association of Coronary Calcium Score on Cardiac PET During Pre-Kidney Transplant Assessment with Persisten...Ann Transplant In Press; DOI: 10.12659/AOT.943532
14 Mar 2024 : Original article
Impact of Blood Products Transfusion on Patients in the Immediate Post-Lung Transplant Period: A Cohort StudyAnn Transplant In Press; DOI: 10.12659/AOT.943652
14 Mar 2024 : Case report
Treatment of Cavernous Transformation of Portal Vein Caused by Hepatic Cystic Echinococcosis Using Ex Vivo ...Ann Transplant In Press; DOI: 10.12659/AOT.942358
Most Viewed Current Articles
05 Apr 2022 : Original article
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
12 Jan 2022 : Original article
Risk Factors for Developing BK Virus-Associated Nephropathy: A Single-Center Retrospective Cohort Study of ...DOI :10.12659/AOT.934738
Ann Transplant 2022; 27:e934738
22 Nov 2022 : Original article
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
15 Mar 2022 : Case report
Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...DOI :10.12659/AOT.935860
Ann Transplant 2022; 27:e935860